Why the study?
Does sequential ultrafiltration and haemodialysis reduce plasma Ir-ANP levels in volume-expanded patients with chronic renal failure?
Does sequential ultrafiltration and haemodialysis reduce plasma Ir-ANP levels in volume-expanded patients with chronic renal failure?
Answers are grounded in this paper and cite their sources.
Plasma ANP levels decrease with fluid removal during ultrafiltration and hemodialysis, supporting the hypothesis that ANP secretion is driven by volume status.
Plasma immunoreactive human atrial natriuretic peptide (Ir-ANP) levels were measured in eight patients with chronic renal failure who were volume-expanded and during treatment by sequential ultrafiltration and haemodialysis. One patient was studied at two separate treatment sessions. Plasma Ir-ANP levels were raised in all patients (mean +/- SE 184 +/- 44 pmol/l, n = 9) compared with healthy controls (11 +/- 1.4 pmol/l), but showed considerable inter-patient variability. Plasma Ir-ANP levels fell with fluid removal during ultrafiltration (123 +/- 30 pmol/l, n = 9, P less than 0.02) and again as fluid was removed during haemodialysis (76 +/- 20 pmol/l, n = 9, P less than 0.02). Seven patients studied 48 h later, before their next dialysis treatment, had regained weight and showed a coincident rise in circulating plasma Ir-ANP (130 +/- 33 pmol/l, n = 7). Our data would support the hypothesis that the secretion of ANP is determined by volume or by a stimulus related to volume. However, it does not exclude the possibility that a factor other than extracellular fluid volume expansion contributes to the raised plasma Ir-ANP levels in chronic renal failure.
No takes yet. Share an insight, caveat, or question.
Wilkins et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: